OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Release Date
2025
(2)
2024
(2)
2021
(2)
2023
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real-World Study in Taiwan.
Not available
S-EPMC12123172
|
biostudies-literature
Cite
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Not available
S-EPMC10776298
|
biostudies-literature
Cite
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Not available
S-EPMC8648748
|
biostudies-literature
Cite
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Not available
S-EPMC10042416
|
biostudies-literature
Cite
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Not available
S-EPMC8252422
|
biostudies-literature
Cite
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
Not available
S-EPMC11014878
|
biostudies-literature
Cite
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Not available
S-EPMC12675286
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets